In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...
Immune cells (NK and cytotoxic T cells) are activated by short-synthetic mRNA which binds to the ZC3H12D receptor and is transported to the nucleus where it induces the expression of GZMB, a key ...
– Initial translational results support proof-of-mechanism with immune reprogramming resulting in tumor penetration and pro-inflammatory alteration in the TME – CAMBRIDGE, Mass., May 30, 2025 ...
Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m in the 2025's year to date (YTD), according to GlobalData’s Pharma ...
Researchers from The University of Osaka in collaboration with Baylor College of Medicine have developed a new therapy for a ...
Australian scientists have developed a biosensor that can rapidly detect the heart failure biomarker S100A7 in saliva, ...
Scientists in NSW have developed a potential world-first mRNA vaccine to protect cattle from foot and mouth disease. The ...
Biomedical engineers at Duke University have demonstrated a new synthetic approach that turbocharges bacteria into producing more of a specific protein, even proteins that would normally destroy them, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback